Pancreatic Cancer Early Detection Program (NCT02206360) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Pancreatic Cancer Early Detection Program
United States100 participantsStarted 2014-04
Plain-language summary
Early detection testing is recommended for individuals at elevated risk for the development of Pancreatic Cancer. This Protocol will define sufficiently elevated risk as either equal to or greater than five times the general population risk, or five times the average risk (1.5%) of developing pancreatic cancer by age 70; that is a 7.5% lifetime risk. Our inclusion criteria has a strong focus on the risk for pancreatic cancer imparted by the presence of hereditary cancer genes, as well as by family history. Enrolled subjects will undergo Endoscopic Ultrasound (EUS) alternating with Magnetic Resonance Imaging (MRI), every six to 12 months, for up to 5 years.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Known carrier of either the BRCA2 or CDKN2A mutation;
✓. Known carrier of any of the following mutations (BRCA1, MLH1, MSH2, PMS2, MSH6, EPCAM , P53, PALB2, APC, or ATM) PLUS first or second degree relative affected with pancreatic cancer;
✓. Individual with Peutz-Jeghers Syndrome;
✓. Familial Pancreatic Cancer, defined as at least two affected relatives with Pancreatic Cancer, who are first degree relatives with each other, and at least one of those affected must be first degree relative to the study subject;
✓. Both parents affected, any age:
✓. Any first degree relative diagnosed with pancreatic cancer under age 50;
✓. Chronic Pancreatitis Syndrome, defined by either PRSS1 or SPINK1 mutations AND appropriate clinical and family history
Exclusion criteria
✕. Any medical condition that contraindicates endoscopy or biopsy
✕. Any medical condition that contraindicates MRI
What they're measuring
1
Premalignant or malignant pancreatic conditions found with alternating EUS and MRI testing.
✕. Status post partial or complete resection of the pancreas
✕. History of pancreatic cancer, either endocrine or exocrine
✕. Clinical suspicion of pancreatic cancer, or any previous radiographic or histologic diagnosis of a pre-malignant finding, including IPMN (Intraductal papillary mucinous neoplasm) and PanIN (Pancreatic intraepithelial Neoplasm).
✕. diagnosis of dementia
✕. Uncontrolled, current illness
✕. Renal insufficiency with serum creatinine greater than 2.0 mg/dl